| Home | E-Submission | Sitemap | Editorial Office |  
Korean J Urol Oncol > Volume 7(1); 2009 > Article
The Korean Journal of Urological Oncology 2009;7(1): 6-11.
비근침윤성 방광암의 방광내 약물투여요법
류 현 열, 김 택 상
고신대학교 의과대학 비뇨기과학교실
Update of Intravesical Therapy on Non-Muscle Invasive Bladder Cancer
Hyun Yul Rhew , Taek Sang Kim
Department of Urology, Gospel Hospital, College of Medicine, Kosin University, Busan, Korea
Published online: April 1, 2009.
For non-muscle invasive bladder cancer, intravesical pharmacotherapy after transurethral resection of bladder tumor is widely used for reducing recurrence and progression. All patients with non-muscle invasive bladder cancer, an immediate instillation after transurethral resection of bladder tumor is needed for reduce recurrence. For intermediate and high risk non-muscle invasive bladder cancer patients, adjuvant intravesical chemotherapy or immunotherapy is advised, especially, intravesical BCG instillation is proven to reduce progression. After recurrence or progression, there are many strategies such as second-line intravesical chemotherapy, immunotherapy, device-assisted therapies, or radical cystectomy. We reviewed and summarized the current status of intravesical chemotherapy and immunotherapy. (Korean J Urol Oncol 2009;7:6-11)
Key Words: Bladder cancer; Intravesical chemotherapy; Immunotherapy
Editorial Office
Department of Urology, Chung-Ang University Hospital
102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-1819   Fax: +82-2-6294-1406   E-mail: journal@kjuo.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Urological Oncology Society and The Korean Prostate Society.                 Developed in M2PI
Close layer
prev next